Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis

Movement Disorders

Volumn 24, Issue 14, 2009, Pages 2143-2148

  Pradat, Pierre François ^a   Bruneteau, Gaelle ^a   Munerati, Elisabetta ^a   Salachas, François ^a   Le Forestier, Nadine ^a   Lacomblez, Lucette ^a   Lenglet, Timothee ^a   Meininger, Vincent ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Amyotrophic lateral sclerosis; Balance; Extrapyramidal system; Shortening reaction; Stiffness

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BALANCE IMPAIRMENT; BODY EQUILIBRIUM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; LEG MUSCLE; MALE; MUSCLE CONTRACTION; MUSCLE RIGIDITY; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PYRAMIDAL SIGN; RATING SCALE; SPASTICITY;

ACTIVITIES OF DAILY LIVING; AMYOTROPHIC LATERAL SCLEROSIS; BASAL GANGLIA DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT; MUSCLE, SKELETAL; OBSERVER VARIATION; POSTURAL BALANCE; POSTURE; PROSPECTIVE STUDIES; PYRAMIDAL TRACTS;

EID: 70450214956     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22762     Document Type: Article

References (43)

1. Charcot JM. Sclérose des cordons latéraux de la moelle épinière chez une femme hystérique atteinte de contractures permanentes des quatre membres. Bull Mémoire Soc Med Hop Paris 1865;2:24-35.
2. Cruveilhier J. Sur la paralysie musculaire progressive atrophique. Arch Gen Med 1853;91:561-603.
3. Charcot. Contribution à l'étude de l'atrophie musculaire progressive type Aran-Duchenne. Paris: 1895.
4. Charcot JM, Gombault M. Note sur un cas d'atrophie musculaire progressive spinale protopathique (type Aran-Duchenne). Arch Physiol 1875;2:735-755.
5. Déjerine J, Thomas A. Polyomyélite antérieure chronique. Maladies de la moelle épinière. Paris: Baillière et fils; 1909. p 496-517.
6. Marie P. Sur la localisation des lésions médullaires dans la sclérose latérale amyotrophique. Soc Med Hop 1893;757-760.
7. Raymond F, Cestan R. Dix huit cas de sclérose latérale amyotrophique avec autopsie. Rev Neurol (Paris) 1905;1:504-508.
8. Norris FH, Jr, KS U, Sachais B, Carey M. Trial of baclofen in amyotrophic lateral sclerosis. Arch Neurol 1979;36:715-716. (Pubitemid 10226319)
9. Przedborski S, Dhawan V, Donaldson DM, et al. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations. Neurology 1996;47:1546-1551. (Pubitemid 26422552)
10. Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 1993;342:1016-1018. (Pubitemid 23314803)
11. Borasio GD, Linke R, Schwarz J, et al. Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I- 123] IPT single photon emission computed tomography. J Neurol Neurosurg Psychiatry 1998;65:263-265. (Pubitemid 28371945)
12. Vogels OJ, Oyen WJ, van Engelen BG, Padberg GW, Horstink MW. Decreased striatal dopamine-receptor binding in sporadic ALS: glutamate hyperactivity? Neurology 1999;52:1275-1277.
13. Vogels OJ, Veltman J, Oyen WJ, Horstink MW. Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor downregulation versus striatal cell degeneration. J Neurol Sci 2000;180:62-65. (Pubitemid 30847675)
14. Burrow JN, Blumbergs PC. Substantia nigra degeneration in motor neurone disease: a quantitative study. Aust N Z J Med 1992;22:469-472.
15. Iwanaga K, Hayashi S, Oyake M, et al. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration. J Neurol Sci 1997;146:139-143. (Pubitemid 27112833)
16. Ince PG, Lowe J, Shaw PJ. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998;24:104-117. (Pubitemid 28175040)
17. Desai J, Swash M. Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion. J Neurol Neurosurg Psychiatry 1999;67:214-216. (Pubitemid 29326956)
18. Adams RD, Victor M. Principles of Neurology, 5th ed. New York: McGraw-Hill; 1993.
19. Broberg C, Grimby G. Measurement of torque during passive and active ankle movements in patients with muscle hypertonia. A methodological study. Scand J Rehabil Med Suppl 1983;9:108-117. (Pubitemid 14135055)
20. Foix C. Sur le tonus et les contractures. Rev Neurol (Paris) 1924;2:1-22.
21. Webster DD. Rigidity in extrapyramidal disease. J Neurosurg 1966;24:299-307.
22. Westphal C. Unterschenkel phänomen und nervendehnung. Arch Psychiatr Nervenkr 1877;7:666-670.
23. Katz R, Rondot P. Muscle reaction to passive shortening in normal man. Electroencephalogr Clin Neurophysiol 1978;45:90-99. (Pubitemid 8385254)
24. Andrews CJ, Burke D, Lance JW. The response to muscle stretch and shortening in Parkinsonian rigidity. Brain 1972;95:795-812.
25. Angel RW, Lewitt PA. Unloading and shortening reactions in Parkinson's disease. J Neurol Neurosurg Psychiatry 1978;41:919-923.
26. Angel RW. Shortening reaction in normal and parkinsonian subjects. Neurology 1982;32:246-251.
27. Broman T. Electromyo-mechanographic registration of passive movements in normal and pathological subjects. Acta Psychiatr Scand (Suppl) 1949;53:1-63.
28. Xia R, Rymer WZ. The role of shortening reaction in mediating rigidity in Parkinson's disease. Exp Brain Res 2004;156:524-528. (Pubitemid 38822621)
29. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124:96-107.
30. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-207.
31. Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, editors. Recent developments in Parkinson's disease. New Jersey: MacMillan Healthcare Information; 1987. p 153-163.
32. Foix C, Thevenard A. Le réflexe de posture. Rev Neurol (Paris) 1924;30:449-468.
33. Rondot P, Scherrer J. Contraction réflexe provoquée par le raccourcissement passif du muscle dans l'athétose et les dystonies d'attitudes. Rev Neurol (Paris) 1966;114:329-337.
34. Berg K, Wood-Dauphinee S, Williams JI. The balance scale: reliability assessment with elderly residents and patients with an acute stroke. Scand J Rehabil Med 1995;27:27-36.
35. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21. (Pubitemid 29502501)
36. Fleiss JL. Statistical methods for rates and proportion, 2nd ed. New York: Wiley Publishers; 1981.
37. Norlinah IM, Bhatia KP, Ostergaard K, Howard R, Arabia G, Quinn NP. Primary lateral sclerosis mimicking atypical parkinsonism. Mov Disord 2007;22:2057-2062.
38. Castaigne P, Lhermitte F, Cambier J, Escourolle R, Le Bigot P. Etude neuropathologique de 61 observations de sclérose latérale amyotrophique. Discussion nosologique. Rev Neurol (Paris) 1972;127:401-414.
39. Sasaki S, Tsutsumi Y, Yamane K, Sakuma H, Maruyama S. Sporadic amyotrophic lateral sclerosis with extensive neurological involvement. Acta Neuropathol (Berl) 1992;84:211-215.
40. Kato S, Oda M, Tanabe H. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1993;19:300-304. (Pubitemid 23237480)
41. Micheletti G, Lannes B, Haby C, et al. Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum. Brain Res Mol Brain Res 1992;14:363-368.
42. Hideyama T, Momose T, Shimizu J, Tsuji S, Kwak S. A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis. Arch Neurol 2006;63:1719-1722. (Pubitemid 44925079)
43. Lloyd CM, Richardson MP, Brooks DJ, Al Chalabi A, Leigh PN. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain 2000;123 (Part 11):2289-2296.